Literature DB >> 10847121

[A simple method for transposing MRI information to simulation films. Technical note].

W Wagner1, K Ostkamp, U Niewöhner-Desbordes.   

Abstract

BACKGROUND: The use of MRI information in the treatment planning process is still expensive and time consuming. Electro-optical devices or specially designed post-processing software in here the risk of picture distortion. PATIENTS AND METHODS: Between June 1998 and June 1999 in 48 patients with brain tumors and 11 patients with carcinoma of the prostate CT treatment planning and MRI were performed with identical patient positioning using the same devices as in the simulation. The transposition of organ and tumor volumes between MRI and simulation film takes place by overlying both on the brightening screen by using a grid. MRI and simulation films must be produced using an identical magnification factor.
RESULTS: For 9 patients with brain tumors and 2 patients with a carcinoma of the prostate the transposition of MRI information on the simulation films showed the necessity of a modification of the shielding or the treatment portals.
CONCLUSIONS: The simple method of direct transposition of MRI structures into simulation films allows to accomplish a verification of the portals and conformation which result of the treatment planning process. Moreover an individualized shielding can also directly be realized.

Entities:  

Mesh:

Year:  2000        PMID: 10847121     DOI: 10.1007/bf03226776

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  10 in total

Review 1.  Sagittal and coronal planes from MRI for treatment planning in tumors of brain, head and neck: MRI assisted simulation.

Authors:  R Pötter; B Heil; L Schneider; H Lenzen; C al-Dandashi; E Schnepper
Journal:  Radiother Oncol       Date:  1992-02       Impact factor: 6.280

2.  MRI-assisted radiation therapy planning of brain tumors--clinical experiences in 17 patients.

Authors:  M Just; H P Rösler; H P Higer; J Kutzner; M Thelen
Journal:  Magn Reson Imaging       Date:  1991       Impact factor: 2.546

3.  [MR tomography and MR angiography--a new method for the planning of the irradiation of large abdominal fields].

Authors:  A Köster; B Kimmig; M Müller-Schimpfle; G Brix; W Semmler; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1992-04       Impact factor: 3.621

4.  Localization of the prostatic apex for radiation treatment planning.

Authors:  O Algan; G E Hanks; A H Shaer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

5.  Use of surface markers for MR radiotherapy planning.

Authors:  G Fischer; D Matthaei; H P Carduck; R Machinek; R Fietkau; E Dühmke
Journal:  Strahlenther Onkol       Date:  1994-03       Impact factor: 3.621

6.  [Representation and transfer of labeled reference structures in X-ray, CT and MR imaging].

Authors:  T Grevelhörster; R Pötter; F J Prott; M Dittrich
Journal:  Strahlenther Onkol       Date:  1995-12       Impact factor: 3.621

7.  Patterns of care survey results: treatment planning for carcinoma of the prostate.

Authors:  R L Gerber; A R Smith; J Owen; A Hanlon; M Wallace; G Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

8.  Integration of coronal magnetic resonance imaging (MRI) into radiation treatment planning of mediastinal tumors.

Authors:  M Flentje; D Zierhut; P Schraube; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1993-06       Impact factor: 3.621

9.  Integration of magnetic resonance imaging into radiation therapy treatment planning: I. Technical considerations.

Authors:  B A Fraass; D L McShan; R F Diaz; R K Ten Haken; A Aisen; S Gebarski; G Glazer; A S Lichter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-12       Impact factor: 7.038

10.  Analysis of prostate and seminal vesicle motion: implications for treatment planning.

Authors:  C J Beard; P Kijewski; M Bussière; R Gelman; D Gladstone; K Shaffer; M Plunkett; P Castello; C N Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-15       Impact factor: 7.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.